時間：111年3月7日(一) 12:10AM – 13:10PM
(Time: 12:10 PM, 8th March )
地點：醫學二館221
(Location: Rm221, Medical Building II)
講者(Speaker)：王紹丞醫師(衛生福利部桃園醫院精神科主任)
(Shao-Cheng, Wang, M.D., Ph.D., Chair of Psychiatry Department at Taoyuan General Hospital, Ministry of Health and Welfare, Taiwan)
Title：精準醫學應用於酒癮治療和藥物研發
(Precision Mental Healthcare in Alcohol Addiction & Drug Discovery)
Dr. Shao-Cheng, Wang, graduated from the School of Medicine, National YangMing University. After training as a psychiatrist, he was admitted to public funds and studied abroad, and obtained a doctorate in public health from Johns Hopkins University. After returning to Taiwan and serving in the countryside, he is currently the director of the Department of Psychiatry at Taoyuan Hospital of the Ministry of Health and Welfare. At present, there are two research directions. One is to apply precision medicine to the treatment of alcohol abuse, to analyze the correlation between the treatment of Taiwanese alcoholic patients receiving acamprosate and naltrexone and the distribution of epidemic diseases, and to link the national health insurance database to analyze the The relationship between the treatment of alcohol addiction patients in Taiwan and their socioeconomic status and physical and psychological comorbidities, and the genetic sequencing of the cases can be used as one of the tools to assess the risk grading of alcohol addiction patients, and can be used for various alcohol addiction treatments. Model efficacy provides personalized predictive models. The second is to use the concept of compound treatment agents for drug research and development, to conduct systematic literature review and Google patent search for multiple drugs and compound preparations, and to analyze medical information in the health insurance database to obtain possible compound drug types and doses. Indications, to establish a foundation for subsequent technology transfer.